Company: SOS
Filing Date: 2025-06-25
Form Type: F-3/A
Source: 0001213900-25-057886
Chunk: 95

Company: SOS Ltd
Filing Date: 2025-06-25
Form: F-3/A
Chunk 95
---
 office indicated in the prospectus supplement, we will, as soon
as possible, forward the securities or other rights that the warrant holder has purchased. If the warrant holder exercises less than all
of the warrants represented by the warrant certificate, we will issue a new warrant certificate for the remaining warrants. If we so indicate
in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.

Prior to the exercise of any
warrants to purchase ADSs or preferred shares of the relevant class or series, holders of the warrants will not have any of the rights
of holders of ADSs or preferred shares purchasable upon exercise, including the right to vote or to receive any payments of dividends
or payments upon our liquidation, dissolution or winding up on the ADSs or preferred shares purchasable upon exercise, if any.

<div align='center'>55

DESCRIPTION OF RIGHTS</div>

We may issue rights to purchase our securities.
The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights offering, we
may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters
or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. Each series of rights will
be issued under a separate rights agent agreement to be entered into between us and one or more banks, trust companies or other financial
institutions, as rights agent, that we will name in the applicable prospectus supplement. The rights agent will act solely as our agent
in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any holders of rights
certificates or beneficial owners of rights.

The prospectus supplement relating to any rights
that we offer will include specific terms relating to the offering, including, among other matters:

| ● | the date of determining the security holders entitled to the rights distribution; |

| ● | the aggregate number of rights issued and the aggregate amount of securities purchasable upon exercise of the rights; |

| ● | the exercise price; |

| ● | the conditions to completion of the rights offering; |

| ● | the date on which the right to exercise the rights will commence and the date on which the rights will expire; and |

| ● | any applicable federal income tax considerations. |

Each right would entitle the holder of the rights
to purchase for cash the principal amount of securities